|Study Description:||The goal of this clinical research study is to learn if ponatinib can help to |
control CML in chronic phase. The safety of this drug will also be studied.
Ponatinib is designed to block the function of BCR-ABL, which is the abnormal
protein responsible for causing leukemia in certain cells.